[Clinical study of jiuxin fumai injection in treatment of cardiogenic shock].
To increase the cure and improvement rates and to decrease the mortality rate in the treatment of cardiogenic shock. Thirty-one patients with cardiogenic shock were studied, and received Jiuxin Fumai injection (JXFM) in research group (n = 20) or dopamine (DA) in control group (n = 11). Eighteen effective cases (90.0%) and 2 ineffective cases (10.0%) in JXFM group, 9 effective cases (81.8%) and 2 ineffective cases (18.2%) in DA group. There was significant difference statistically, P > 0.05. JXFM and DA had the same effect in elevating blood pressure, enhancing pump function of the heart and ameliorating collapse syndrome. They are safe, effective, convenient for use and prompt in responding. However, JXFM showed raising blood pressure faster, higher as well as more stable, and the dual phase phenomenon in adjusting heart rate, which could slow down tachycardia as well as speed up bradycardia were observed.